Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5098.5000 -196.00 (-3.70%)

NSE May 30, 2025 15:31 PM

Volume: 724.8K

High volume today

Alkem Laboratories Ltd.

05 Feb 2022

5098.50

-3.70%

Alkem Labs (HOLD): Strong domestic growth; weak margins

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Robust traction in India formulations (+20% YoY) during Q3, partly offset by a 7% decline in US generic revenue

Alkem Laboratories L.. has an average target of 5278.50 from 2 brokers.